Embecta Corp. is a global medical technology company focused on improving the health and well-being of people living with diabetes. The company develops, manufactures, and commercializes insulin delivery products, including pen needles, syringes, and safety devices used in diabetes care. Embecta is headquartered in Parsippany, New Jersey, and became an independent public company in 2022 following its spin-off from Becton, Dickinson and Company. The business serves customers in numerous countries worldwide through a broad commercial and distribution network. For fiscal 2023, embecta reported revenue of approximately $1.1 billion. The company employs roughly 2,000 people.
Verified Email Pattern
{first}.{last}@embecta.com
d****@embecta.com
e****@embecta.com
Find a verified email at embecta
Look up any prospect by name, or by name and company, across 110M contacts.
Employees Directory
Showing 12 of 12 employees with verified contact records
| Name | Location | Verified Email |
|---|---|---|
|
Danielle Francois
Talent Acquisition Manager - EMEA
|
|
d****@embecta.com
|
|
Emmanuelle Huguet
Professional at Embecta
|
e****@embecta.com
|
|
|
GAËL TANGUY
Operations Specialist
|
|
g****@embecta.com
|
|
Geoffrey Dorieux
Operations Specialist
|
|
g****@embecta.com
|
|
Isabelle CAPET
Specialist
|
|
i****@embecta.com
|
|
Katerina Zakrzewska
Project Specialist
|
|
k****@embecta.com
|
|
Mariana Buss
Specialist
|
|
m****@embecta.com
|
|
Matthew Prendeville
Operations Manager
|
|
m****@embecta.com
|
|
Peter Wallentin
Professional at Embecta
|
|
p****@embecta.com
|
|
Richard Laurits
Operations Specialist
|
|
r****@embecta.com
|
|
Roxane Daunt
Operations Specialist
|
|
r****@embecta.com
|
|
Wendy Hork
Professional at Embecta
|
|
w****@embecta.com
|
Protected by reCAPTCHA. Google Privacy Policy and Terms of Service apply.